Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by fairweather1on Jul 22, 2014 12:02pm
244 Views
Post# 22769876

RE:Open Question on Financi

RE:Open Question on Financi
the poster was me, and I think your plan to ask TLT rep is the right way to go.  As I think I mentioned in a followup,  the I.R. rep at the time may have misunderstood what I was asking (although there was no question in my mind that I was wondering how much more cash they needed to get into the first human trial, and I have no question that he answered they would not need more cash).

I was pretty naive about the company at the time that I spoke with the rep, and I assumed at the time that the reason they wouldn't need financing was their high expectations of revenue from the next laser iteration.  Please understand, when I made the comment in an earlier post, it was an "aside" and not the main topic of that post.

I look forward to the response from TLT, but from what I am learning, I expect they will say that they need some financing.
Bullboard Posts